Local paclitaxel delivery for the prevention of restenosis: Biological effects and efficacy in vivo

Journal of the American College of Cardiology

Volumn 35, Issue 7, 2000, Pages 1969-1976

  Herdeg, Christian ^a   Oberhoff, Martin ^a   Baumbach, Andreas ^a   Blattner, Andreas ^a   Axel, Dorothea I ^a   Schröder, Stephen ^a   Heinle, Helmut ^a   Karsch, Karl R ^a  

^a Dept Med Dept Physiol Univ T ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; PACLITAXEL; SODIUM CHLORIDE; TRITIUM; TUBULIN;

ANGIOPLASTY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA; ARTICLE; BALLOON CATHETER; BALLOON DILATATION; BLOOD VESSEL DIAMETER; CAROTID ARTERY DISEASE; CELL MIGRATION; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CYTOSKELETON; DRUG DELIVERY SYSTEM; DRUG EFFICACY; ELECTRON MICROSCOPY; ELECTROSTIMULATION; IN VIVO STUDY; ISOTOPE LABELING; MICROTUBULE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RESTENOSIS; SIGNAL TRANSDUCTION; SWINE; VASOCONSTRICTION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CONSTRICTION, PATHOLOGIC; PACLITAXEL; RABBITS; RECURRENCE; SWINE; VASCULAR DISEASES;

EID: 0034081030     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00614-8     Document Type: Article

References (38)

1. Schiff P.B., Fant J., Horwitz S.B. Promotion of microtubule assembly in vitro by taxol. Nature. 277:1979;665-667.
2. Schneider B. Taxol. Ein Arzneistoff aus der Rinde der Eibe. Deutsche Apotheker Zeitung 1996;134:19-30.
3. Rowinsky E.K., Donehower R.C. Paclitaxel (Taxol). N Engl J Med. 332:1995;1004-1014.
4. Straubinger R.M., Sharma A., Murray M., Mayhew E. Novel taxol formulations taxol-containing liposomes . Monogr Natl Cancer Inst. 15:1993;69-78.
5. Jordan M.A., Toso R.J., Thrower D., Wilson L. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci USA. 90:1993;9552-9556.
6. Axel D.I., Kunert W., Göggelmann C., et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation. 96:1997;636-645.
7. Sollot S.J., Cheng L., Pauly R.R., et al. Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat. J Clin Invest. 95:1995;1869-1876.
8. Sauro MD, Camporesi DA, Sudakow RL. The anti-tumor agent, taxol, attenuates contractile activity in rat aortic smooth muscle. Life Sciences 1996;56:PL157-61.
9. Hanke H., Strohschneider T., Oberhoff M., et al. Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty. Circ Res. 67:1990;651-659.
10. Hanke H., Haase K.K., Hanke S., et al. Morphological changes and smooth muscle cell proliferation after experimental excimer laser treatment. Circulation. 83:1991;1380-1389.
11. Betz E., Schlote W. Responses of vessel walls to chronically applied electric stimuli. Basic Res Cardiol. 74:1979;10-20.
12. Tsukada T., Rosenfeld M., Ross R., Gown A.M. Immunocytochemicel analysis of cellular components in atherosclerotic lesions use of monoclonal antibodies with the Watanabe and fat-fed rabbit . Arteriosclerosis. 6:1986;601-613.
13. Gabbiani G., Kocher O., Bloom W.S. Actin expression in smooth muscle cells of rat aortic intimal thickening, human atheromatous plaque, and cultured rat aortic media. J Clin Invest. 74:1984;148-152.
14. Dartsch P.C., Ritter M., Häussinger D., Lang F. Cytoskeletal reorganization in NIH 3T3 fibroblasts expressing the ras oncogene. Eur J Cell Biol. 63:1994;316-325.
15. Dartsch P.C., Voisard R., Bauriedel G., et al. Growth characterisitics and cytoskeletal organization of cultured smooth muscle cells from human primary stenosing and restenosing lesions. Arteriosclerosis. 10:1990;62-75.
16. Heinle H. Vasoconstriction of carotid artery induced by hydroperoxides. Arch Int Physiol Biochem. 92:1984;267-271.
17. Baumbach A., Oberhoff M., Kunert W., et al. Vascular contractile function following experimental excimer laser angioplasty. Lasers Med Sci. 10:1995;25-30.
18. Lincoff A.M., Topol E.J., Ellis S.G. Local drug delivery for the prevention of restenosis. Fact, fancy and future. Circulation. 90:1994;2070-2082.
19. O'Keefe J.H.J., McCallister B.D., Bateman T.M., et al. Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty. J Am Coll Cardiol. 19:1992;1597-1600.
20. Muller D.W.M., Topol E.J., Abrams G.D., et al. Intramural methotrexate therapy for the prevention of neointimal thickening after balloon angioplasty. J Am Coll Cardiol. 20:1992;460-466.
21. Wani M.C., Taylor H.L., Wall M.E., et al. Plant antitumor agents, VI the isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia . J Am Chem Soc. 93:1971;2325-2327.
22. Nishio K., Arioka H., Ishida T., et al. Enhanced interactions between tubulin and microtubule-associated protein 2 via inhibition of MAP kinase and CDC2 kinase by paclitaxel. Int J Cancer. 63:1995;688-693.
23. Ding A.H., Sanchez E., Nathan C.F. Taxol shares the ability of bacterial lipopolysaccharide to induce tyrosine phosphorylation of microtubule-associated protein kinase. J Immunol. 151:1993;5596-5602.
24. Rosette C., Karin M. Cytoskeletal control of gene expression depolymerization of microtubules activates NF-kB . Circulation. 86:1995;100-110.
25. Rowinsky E.K., McGuire W.P., Guarnieri T., et al. Cardiac disturbances during the administration of taxol. J Clin Oncol. 9:1991;1704-1712.
26. Rowinsky E.K., Eisenhauer E.A., Chaudhry V., et al. Clinical toxicities encountered with paclitaxel (Taxol). Semin Oncol. 20:1993;1-15.
27. Leu J.-G., Chen B.-X., Schiff P.B., Erlanger B.F. Characterization of polyclonal and monoclonal anti-taxol antibodies and measurement of taxol in serum. Cancer Res. 53:1993;1388-1391.
28. Wilensky R.L., March K.L., Hathaway D.R. Direct intraarterial wall injection of microparticles via a catheter a potential drug delivery strategy following angioplasty . Am Heart J. 122:1991;1136-1140.
29. Lambert C.R., Leone J.E., Rowland S.M. Local drug delivery catheters functional comparison of porous and microporous designs . Coron Artery Dis. 4:1993;469-475.
30. Wilensky R.L., March K.L., Gradus-Pizlo I., et al. Regional and arterial localization of radioactive microparticles after local delivery by unsupported or supported porous balloon catheters. Am Heart J. 129:1995;852-859.
31. Fram D.B., Aretz T., Azrin M.A., et al. Localized intramural drug delivery during balloon angioplasty using hydrogel-coated balloons and pressure-augmented diffusion. J Am Coll Cardiol. 23:1994;1570-1577.
32. Oberhoff M., Herdeg C., Baumbach A., et al. Time course of smooth muscle cell proliferation after local drug delivery of low molecular weight heparin using a porous balloon catheter. Cathet Cardiovasc Diagn. 41:1997;268-274.
33. Camenzind E., Bakker W., Reijs A., et al. Site-specific intracoronary heparin delivery in humans after balloon angioplasty. A radioisotopic assessment of regional pharmacokinetics. Circulation. 96:1997;154-165.
34. Horwitz S.B., Lothstein L., Manfredi J.J., et al. Taxol mechanisms of action and resistance . Ann NY Acad Sci. 466:1986;733-744.
35. De Brabander M., Geuens G., Nuydens R., et al. Taxol induces the assembly of free microtubules in living cells and blocks the organizing capacity of the centrosomes and kinetochores. Proc Natl Acad Sci USA. 78:1981;5608-5612.
36. Stary H.C., Blankenhorn D.H., Chandler A.B., et al. A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the committee on vascular lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 85:1992;391-405.
37. Mintz G.S., Popma J.J., Pichard A.D., et al. Arterial remodeling after coronary angioplasty. A serial intravascular ultrasound study. Circulation. 94:1996;35-43.
38. Herdeg C., Oberhoff M., Baumbach A., et al. Local drug delivery with porous balloons in the rabbit assessment of vascular injury for an improvement of application parameters . Cathet Cardiovasc Diagn. 41:1997;308-314.